A CpG island has been identified in the TET1 promoter and in the exon 1 region, which is commonly methylated in B-cell malignancies including both Hodgkin’s and non-Hodgkin’s lymphomas, NK/T-cell lymphomas, and MM [44, 127, 128]. This evidence concerns the gene TET1 and Miyoshi myopathy.